{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:42:00Z","timestamp":1791654120469,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011880","name":"Acad\u00e9mie de recherche et d'enseignement sup\u00e9rieur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cryptococcal meningitis is mainly caused by <jats:italic>Cryptococcus neoformans\/C. gattii<\/jats:italic> complex. We compared the clinical, biological, and antifungal susceptibility profiles of isolates from HIV-Infected Patients (HIVIP) with <jats:italic>C. neoformans<\/jats:italic> (<jats:italic>Cn<\/jats:italic>) versus <jats:italic>C. curvatus\/C. laurentii<\/jats:italic> (<jats:italic>Cc\/Cl<\/jats:italic>) meningitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Comparative analytical study were conducted. Apart from patients\u2019 clinical data, the following analysis were performed and the results were compared in both groups: biochemical examination, cryptococcal antigen test, India ink staining, and culture on Cerebral Spinal Fluid (CSF), strains identification by mass spectrometry, ITS sequencing, PCR serotyping and antifungal susceptibility. The main outcome variable was the \u201cspecies of <jats:italic>Cryptococcus<\/jats:italic> identified\u201d, which was compared to other variables of the same type using the Pearson Chi-square test or the Fisher exact test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 23 (79.3%) <jats:italic>Cn<\/jats:italic> meningitis cases versus 6 (20.7%) <jats:italic>Cc\/Cl<\/jats:italic> meningitis were retained<jats:italic>.<\/jats:italic><jats:italic>Cn<\/jats:italic> meningitis was more frequently associated with headache (100% vs 50%, <jats:italic>p<\/jats:italic>\u2009=\u20090.005) than <jats:italic>Cc\/Cl<\/jats:italic> meningitis and meningeal signs were more frequent in <jats:italic>Cn<\/jats:italic> infected patients. Biologically, hypoglycorrhachia and low CD<jats:sub>4<\/jats:sub> count were more observed in <jats:italic>Cn<\/jats:italic> group (90% vs 20% of patients, <jats:italic>p<\/jats:italic>\u2009=\u20090.01; 45.6 vs 129.8\u00a0cells\/\u00b5L, <jats:italic>p<\/jats:italic>\u2009=\u20090.02, respectively). A higher proportion of <jats:italic>Cn<\/jats:italic> strains (91.3%) showed a low Minimum Inhibitory Concentration (MIC) (&lt;\u20098\u00a0mg\/L) for fluconazole compared to <jats:italic>Cc\/Cl<\/jats:italic> strains (66.7%). Also, <jats:italic>Cc\/Cl<\/jats:italic> strains resistant to 5-flucytosine and amphotericin B were found in 16.7% of cases for each of the two antifungal agents. <jats:italic>Cryptococcus<\/jats:italic> detection by routine analysis (India ink, culture, and antigens) was better for <jats:italic>Cn<\/jats:italic> samples than <jats:italic>Cc\/Cl<\/jats:italic>. Except ITS sequencing, which identified all strains of both groups, mass spectrometry and serotyping PCR identified <jats:italic>Cn<\/jats:italic> strains better than <jats:italic>Cc\/Cl<\/jats:italic> (100% vs 80%, <jats:italic>p<\/jats:italic>\u2009=\u20090.1; 100% vs 0%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, respectively). After treatment with amphotericin B, 5-flucytosine, and fluconazole in both groups, the outcome was similar.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Clinical presentation of <jats:italic>Cn<\/jats:italic> meningitis is certainly more severe than that of <jats:italic>Cc\/Cl<\/jats:italic> meningitis, but <jats:italic>Cc\/Cl<\/jats:italic> infection should be considered in the management of HIVIP with meningeal syndrome because of the diagnostic difficulty and the high MICs of antifungal agents required for the treatment of meningitis due to these cryptococcal species.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06849-3","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T09:02:46Z","timestamp":1636966966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of clinical and biological characteristics of HIV-infected patients presenting Cryptococcus neoformans versus C. curvatus\/C. laurentii meningitis"],"prefix":"10.1186","volume":"21","author":[{"given":"Bive","family":"Zono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Moutschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hippolyte","family":"Situakibanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Sacheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaultier","family":"Muendele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pius","family":"Kabututu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolphe","family":"Biakabuswa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Landu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Mvumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Hayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"6849_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1567-1364.2006.00088.x","volume":"6","author":"KJ Kwon-Chung","year":"2006","unstructured":"Kwon-Chung KJ, Varma A. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res. 2006;6:574\u201387.","journal-title":"FEMS Yeast Res"},{"key":"6849_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/cid\/cit341","volume":"57","author":"SCA Chen","year":"2013","unstructured":"Chen SCA, Korman TM, Slavin MA, Marriott D, Byth K, Bak N, et al. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis. 2013;57:543\u201351.","journal-title":"Clin Infect Dis"},{"key":"6849_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s15010-007-6142-8","volume":"35","author":"T Khawcharoenporn","year":"2007","unstructured":"Khawcharoenporn T, Apisarnthanarak A, Mundy LM. Non-neoformans cryptococcal infections: a systematic review. Infection. 2007;35:51\u20138.","journal-title":"Infection"},{"key":"6849_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1439-0507.1998.tb00338.x","volume":"41","author":"LB Johnson","year":"1998","unstructured":"Johnson LB, Bradley SF, Kauffman CA. Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses. 1998;41:277\u201380.","journal-title":"Mycoses"},{"key":"6849_CR5","doi-asserted-by":"publisher","first-page":"10436","DOI":"10.1016\/j.biortech.2011.08.102","volume":"102","author":"M Thiru","year":"2011","unstructured":"Thiru M, Sankh S, Rangaswamy V. Process for biodiesel production from Cryptococcus curvatus. Bioresour Technol. 2011;102:10436\u201340. https:\/\/doi.org\/10.1016\/j.biortech.2011.08.102.","journal-title":"Bioresour Technol"},{"key":"6849_CR6","first-page":"285","volume":"14","author":"J Nowicka","year":"2007","unstructured":"Nowicka J, Nawrot U, Haus O, Kuliczkowski K, Fonteyne PA, Nolard N. Cryptococcus curvatus in peritoneal fluid of gastric lymphoma patient with complex chromosome aberrations\u2014case report. Mikol Lek. 2007;14:285\u20137.","journal-title":"Mikol Lek"},{"key":"6849_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12019-003-0012-9","volume":"29","author":"LH Mccurdy","year":"2003","unstructured":"Mccurdy LH, Billings FT. Infections due to non-neoformans cryptococcal species. Comp Ther. 2003;29:95\u2013101.","journal-title":"Comp Ther"},{"issue":"8","key":"6849_CR8","first-page":"587","volume":"31","author":"RM Jacobs","year":"1990","unstructured":"Jacobs RM, Cochrane SM, Lumsden JH, Norris AM. Relationship of cerebrospinal fluid protein concentration determined by dye-binding and urinary dipstick methodologies. Can Vet J. 1990;31(8):587\u20138.","journal-title":"Can Vet J"},{"key":"6849_CR9","unstructured":"Library MBTIVD, Library MBTIVD, Ivd MBT, Extension L, Library MBTIVD. Notes de publication. 2019:1\u201361."},{"key":"6849_CR10","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1128\/JCM.39.8.2873-2879.2001","volume":"39","author":"C Ferrer","year":"2001","unstructured":"Ferrer C, Colom F, Fras\u00e9s S, Mulet E, Abad JL, Ali\u00f3 JL. Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections. J Clin Microbiol. 2001;39:2873\u20139.","journal-title":"J Clin Microbiol"},{"key":"6849_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1439-0507.2007.01357.x","volume":"50","author":"S Ito-Kuwa","year":"2007","unstructured":"Ito-Kuwa S, Nakamura K, Aoki S, Vidotto V. Serotype identification of Cryptococcus neoformans by multiplex PCR. Mycoses. 2007;50:277\u201381.","journal-title":"Mycoses"},{"key":"6849_CR12","first-page":"17","volume":"16","author":"MC Arendrup","year":"2015","unstructured":"Arendrup MC, Guinea J, Cuenca-Estrella M, Meletiadis J, Moutonn JW, Lagrou K, et al. Method for the determination of broth dilution minimum Inhibitory concentrations of antifungal agents for yeasts. Print Pap Eur. 2015;16:17.","journal-title":"Print Pap Eur"},{"key":"6849_CR13","unstructured":"Committee TE, Testing AS, Changes N, Pseudomonas E. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. 2015:0\u201377. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_5.0_Breakpoint_Table_01.pdf."},{"key":"6849_CR14","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","volume":"43","author":"MA Pfaller","year":"2005","unstructured":"Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, et al. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol. 2005;43:2163\u20137.","journal-title":"J Clin Microbiol"},{"key":"6849_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11910-019-0993-0","volume":"19","author":"E Temfack","year":"2019","unstructured":"Temfack E, Boyer-Chammard T, Lawrence D, Delliere S, Loyse A, Lanternier F, et al. New insights into Cryptococcus spp. biology and Cryptococcal meningitis. Curr Neurol Neurosci Rep. 2019;19:81.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"6849_CR16","doi-asserted-by":"publisher","first-page":"a019760","DOI":"10.1101\/cshperspect.a019760","volume":"4","author":"KJ Kwon-Chung","year":"2014","unstructured":"Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med. 2014;4:a019760. https:\/\/doi.org\/10.1101\/cshperspect.a019760.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6849_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1155\/2006\/160451","volume":"13","author":"EM Shankar","year":"2006","unstructured":"Shankar EM, Kumarasamy N, Bella D, Renuka S, Kownhar H, Suniti S, et al. Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS. Can Respir J. 2006;13:275\u20138.","journal-title":"Can Respir J"},{"key":"6849_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/0255-0857.108731","volume":"31","author":"P Banerjee","year":"2013","unstructured":"Banerjee P, Haider M, Trehan V, Mishra B, Thakur A, Dogra V, et al. Cryptococcus laurentii Fungemia. Indian J Med Microbiol. 2013;31:75\u20137.","journal-title":"Indian J Med Microbiol"},{"key":"6849_CR19","doi-asserted-by":"crossref","unstructured":"Calista F, Tomei F, Assalone P, Traficante D, Di Pilla G, Pepe C, et al. Cryptococcus laurentii Diarrhea in a Neoplastic Patient. Case Rep Oncol Med. 2015;2015 Figure 2:1\u20132.","DOI":"10.1155\/2015\/216458"},{"key":"6849_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/20009666.2017.1350087","volume":"7","author":"N Smith","year":"2017","unstructured":"Smith N, Sehring M, Chambers J, Patel P. Perspectives on non-neoformans cryptococcal opportunistic infections. J Community Hosp Intern Med Perspect. 2017;7:214\u20137. https:\/\/doi.org\/10.1080\/20009666.2017.1350087.","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"6849_CR21","first-page":"1","volume":"7","author":"EJ Cano","year":"2020","unstructured":"Cano EJ, Yetmar ZA, Razonable RR. Cryptococcus species other than Cryptococcus neoformans and Cryptococcus gattii: are they clinically significant? Open Forum Infect Dis. 2020;7:1\u20134.","journal-title":"Open Forum Infect Dis"},{"key":"6849_CR22","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1128\/JCM.38.4.1468-1471.2000","volume":"38","author":"T Sugita","year":"2000","unstructured":"Sugita T, Takashima M, Ikeda R, Nakase T, Shinoda T. Intraspecies diversity of Cryptococcus laurentii as revealed by sequences of internal transcribed spacer regions and 28S rRNA gene and taxonomic position of C. laurentii clinical isolates. J Clin Microbiol. 2000;38:1468\u201371.","journal-title":"J Clin Microbiol"},{"key":"6849_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11046-011-9500-0","volume":"174","author":"K Ferreira-Paim","year":"2012","unstructured":"Ferreira-Paim K, Andrade-Silva L, Mora DJ, Lages-Silva E, Pedrosa AL, da Silva PR, et al. Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil. Mycopathologia. 2012;174:41\u201352.","journal-title":"Mycopathologia"},{"key":"6849_CR24","first-page":"1214","volume":"40","author":"R Ikeda","year":"2002","unstructured":"Ikeda R, Sugita T, Jacobson ES, Shinoda T. Laccase and melanization in clinically important. Society. 2002;40:1214\u20138.","journal-title":"Society"},{"key":"6849_CR25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/003693308903400404","volume":"34","author":"H Mocan","year":"1989","unstructured":"Mocan H, Murphy A, Beattie T, McAllister T. Fungal peritonitis in cidldren on continuous ambulatory peritoneal dialysis. Scot Med J. 1989;34:494\u20136.","journal-title":"Scot Med J"},{"key":"6849_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3109\/13693780902756073","volume":"48","author":"L Bernal-martinez","year":"2010","unstructured":"Bernal-martinez L, Gomez-lopez A, Castelli MV, Mesa-arango ANAC, Zaragoza O, Rodriguez-tudela JL, et al. Susceptibility profile of clinical isolates of non-Cryptococcus neoformans\/non-Cryptococcus gattii Cryptococcus species and literature review. Med Mycol. 2010;48:90\u20136.","journal-title":"Med Mycol"},{"key":"6849_CR27","unstructured":"World Health Organization. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children, march 2018. Gen\u00e8ve; 2018. http:\/\/www.who.int\/fr."},{"issue":"11","key":"6849_CR28","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1097\/00007611-197311000-00006","volume":"66","author":"JL Theophilo da Cunha","year":"1973","unstructured":"Theophilo da Cunha JL. Cryptococcus albidus meningitis. South Med J. 1973;66(11):1230.","journal-title":"South Med J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06849-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06849-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06849-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T09:07:16Z","timestamp":1636967236000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06849-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6849"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06849-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"22 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was carried out in strict compliance with ethical rules. It has obtained the approval of the Ethics Committee of the Public Health School of the Faculty of Medicine of the University of Kinshasa under the Approval number ESP\/CE\/071\/2019. All patients included in this study were informed of the risks associated with the study and gave their informed consent to participate. Anonymity was guaranteed and the data collected was kept and handled by the research team alone. All methods were carried out in accordance with relevant guidelines and regulations\/Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1157"}}